floatz

floatz is a pioneering AI platform developed by researchers from ETH Zürich, designed to revolutionize the drug discovery and development process. It addresses a critical challenge in the pharmaceutical R&D pipeline: the high failure rate of therapeutic programs due to flawed foundational science. By providing a rigorous, data-driven "Foundational Evidence Audit," floatz replaces guesswork with certainty, enabling biotech companies, pharmaceutical firms, and investors to make confident, evidence-based decisions.

The platform's core mission is to empower scientists by removing the friction in traditional R&D, allowing them to focus on creating breakthrough therapies. It leverages advanced AI to process and synthesize vast amounts of biomedical data far more effectively than manual methods, significantly shortening the timeline from initial hypothesis to a validated therapeutic opportunity.

How to use floatz

The floatz process is a collaborative, three-step methodology that combines powerful AI with expert human oversight:

1. Target Intake & Context Alignment: The process begins when a client submits a nominated therapeutic target. The floatz team collaborates closely with the client to understand the specific therapeutic context, key scientific questions, and the critical investment or development decisions that need to be made. This ensures the subsequent analysis is perfectly aligned with the client's strategic objectives.
2. Systematic Evidence Audit: At the heart of the service, an agent-based AI constructs a comprehensive knowledge graph around the target. This AI system then systematically stress-tests the client's hypothesis. It performs reproducibility checks against all available literature, assesses the methodological quality of key studies, and triangulates scientific claims across a wide range of databases, including genomic, proteomic, patent, and clinical trial data. This 360° audit uncovers potential risks and strengths that might otherwise be missed.
3. Strategic Reporting: The AI-driven analysis is synthesized by floatz's team of expert scientists into a comprehensive Target Validation Package. This isn't just a data dump; it's a clear, actionable narrative. The report includes a confidence score for the target and provides a definitive go/no-go recommendation, empowering clients to proceed with certainty and secure their next round of funding or commit R&D resources effectively.

Core Features of floatz

• AI-Powered Foundational Evidence Audit: Utilizes agent-based AI for in-depth, unbiased analysis of therapeutic targets.
• Systematic Evidence Triangulation: Cross-references data from publications, patents, and genomic & proteomic databases to validate scientific claims.
• Comprehensive Knowledge Graph: Builds a complete, interconnected view of all available information surrounding a biological target.
• Reproducibility and Quality Assessment: Automatically evaluates the methodological rigor and reproducibility of key scientific studies.
• Actionable Target Validation Package: Delivers a clear report with a confidence score and a strategic go/no-go recommendation.
• Expert-Driven Synthesis: Combines AI-generated insights with analysis from experienced scientists to provide a nuanced and reliable report.
• Proprietary Data Integration: Capable of incorporating a client's internal, proprietary data to enrich the analysis.

Use Cases for floatz

floatz is ideal for various stakeholders in the life sciences ecosystem:

• Biotech Startups: To validate a lead therapeutic target and build a compelling, data-backed case to secure seed or Series A funding.
• Pharmaceutical R&D Departments: To prioritize their internal R&D pipeline, de-risk new programs, and make efficient capital allocation decisions.
• Venture Capital and Investors: To conduct unbiased, deep computational due diligence on potential biotech investments, clarifying a target's commercial viability.
• Academic Research Groups: To assess the translational potential of their discoveries and build a strong foundation for commercialization or spin-offs.

Advantages of floatz

floatz offers a distinct strategic advantage:

• Reduce Late-Stage Failures: By identifying flawed foundational science early, it can significantly reduce the risk of costly preclinical and clinical failures.
• Data-Driven Confidence: Moves beyond simple data points to provide a multi-layered, unbiased computational analysis for robust decision-making.
• Accelerate R&D Timelines: Provides clear, actionable insights quickly, guiding go/no-go decisions and shortening the path to development.
• Strengthen Funding Proposals: The Foundational Evidence Audit serves as powerful, independent due diligence to build investor confidence.
• Scientific Rigor and Expertise: Founded by ETH Zürich researchers and backed by the ETH AI Center, ensuring the highest standards of scientific and technological excellence.

Pricing and Plans

floatz operates on a project-based or enterprise service model. The pricing is customized based on the complexity and scope of the target validation project. To get a detailed quote and discuss your specific needs, you are encouraged to contact the floatz team directly for a consultation.